Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-11-08FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approves Ajanta Pharma USA Inc.'s supplemental application for Montelukast Sodium, updating regulatory status for the product.
-
FDA approval · 2019-11-07FDA Approved: CLARITIN CHEWABLE GRAPE AND BUBBLEGUM — Supplemental Application (Bayer HealthCare LLC.)
The FDA approved a supplemental application to add a chewable grape and bubblegum formulation of Claritin (loratadine) from Bayer HealthCare…
-
FDA approval · 2019-11-07FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare's supplemental application for montelukast sodium under ANDA202717, resulting in an updated approved product.…
-
FDA approval · 2019-11-05FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for Montelukast Sodium from Rising Pharma Holdings, Inc., enabling a generic product entry. This dec…
-
FDA label_change · 2019-10-31FDA Approved: CAREONE ALLERGY RELIEF — Supplemental Application (American Sales Company)
FDA approved a supplemental application for CAREONE ALLERGY RELIEF containing fexofenadine HCl, submitted by American Sales Company.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-10-29FDA Approved: BUDESONIDE — Supplemental Application (Rite Aid Corporation)
FDA approved a supplemental application for Budesonide by Rite Aid Corporation, expanding or modifying the approval of this generic product.
-
FDA approval · 2019-10-25FDA Approved: ALLERGY RELIEF 24HR — Supplemental Application (VELOCITY PHARMA LLC)
FDA approved a supplemental application for ALLERGY RELIEF 24HR (levocetirizine dihydrochloride) by Velocity Pharma LLC.
-
FDA approval · 2019-10-22FDA Approved: DESLORATADINE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approves a supplemental application for desloratadine submitted by Dr. Reddy's Laboratories Limited.
-
FDA approval · 2019-10-22FDA Approved: DESLORATADINE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for desloratadine, a generic antihistamine used to treat allergy symptoms.
-
FDA approval · 2019-10-21FDA Approved: GOOD SENSE LEVOCETIRIZINE — Supplemental Application (L. Perrigo Company)
FDA approved a supplemental application for Good Sense Levocetirizine (levocetirizine dihydrochloride) from L. Perrigo Company.
-
FDA approval · 2019-10-18FDA Approved: DESLORATADINE — Supplemental Application (Bionpharma Inc.)
FDA approves a supplemental application for Desloratadine from Bionpharma Inc., confirming the approval of the generic product under ANDA 07…
-
CLINICAL_TRIALS trial_result · 2019-10-16Clinical Trial Update: Steroid Sparing Effect of Nasal Corticosteroid In Asthma And Rhinitis [Phase 4]
Phase 4 trial update on the steroid-sparing effect of a nasal corticosteroid in asthma and allergic rhinitis.
-
CLINICAL_TRIALS trial_result · 2019-10-16Clinical Trial Update: Fluticasone and Salmeterol in Allergic Rhinitis [Phase 4]
Phase 4 clinical trial update evaluating fluticasone and salmeterol for allergic rhinitis has completed.
-
CLINICAL_TRIALS withdrawal · 2019-10-09Clinical Trial Update: Clinical Study, Non Inferiority Between Noex® 32µg Versus Budecort Aqua® 32µg in Treatment of Alergic Rhinitis [Phase 3]
A Phase 3 clinical trial comparing Noex 32µg to Budecort Aqua 32µg for allergic rhinitis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-10-09Clinical Trial Update: Clinical Study, Non Inferiority Between Noex® 50µg Versus Busonid® 50µg in Treatment of Allergic Rhinitis [Phase 3]
Phase 3 non-inferiority study comparing Noex 50µg to Busonid 50µg for allergic rhinitis was withdrawn.
-
CLINICAL_TRIALS trial_result · 2019-10-04Clinical Trial Update: Safety Study of Levocetirizine and Fexofenadine [Phase 4]
Phase 4 safety study investigating levocetirizine and fexofenadine in pruritus and chronic urticaria completed with posted results.
-
FDA approval · 2019-10-03FDA Approved: CLARITIN CHEWABLE GRAPE AND BUBBLEGUM — Supplemental Application (Bayer HealthCare LLC.)
The FDA approved a supplemental application for Claritin Chewable Grape and Bubble Gum (loratadine) by Bayer HealthCare LLC, adding a flavor…
-
FDA approval · 2019-10-03FDA Approved: DESLORATADINE — Supplemental Application (Natco Pharma USA LLC)
The FDA approved a supplemental application for desloratadine from Natco Pharma USA LLC.
-
CLINICAL_TRIALS trial_result · 2019-09-25Clinical Trial Update: Efficacy & Safety of STG320 Sublingual Tablets of HDM Allergen Extracts in Adults and Adolescents With HDM-associated AR [Phase 3]
Phase 3 trial assessing the efficacy and safety of STG320 sublingual tablets containing house dust mite allergen extracts in adults and adol…
-
FDA approval · 2019-09-23FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved a supplemental application for Camber Pharmaceuticals' generic levocetirizine dihydrochloride.
-
FDA approval · 2019-09-13FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
The FDA approved a supplemental application for levocetirizine dihydrochloride from Macleods Pharmaceuticals Limited under ANDA205564.
-
CLINICAL_TRIALS trial_result · 2019-09-13Clinical Trial Update: Efficacy and Safety of SUBLIVAC Phleum for Immunotherapy of Grass Pollen-Allergy [Phase 2]
Phase 2 trial update on SUBLIVAC Phleum for grass pollen allergy shows efficacy and safety data, completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-09-13Clinical Trial Update: Intranasal SB-705498 in Allergic Rhinitis (AR) Patients [Phase 2]
Phase 2 clinical trial update for intranasal SB-705498 in allergic rhinitis completed with posted results.
-
FDA approval · 2019-09-06FDA Approved: ADVIL ALLERGY AND CONGESTION RELIEF — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for ADVIL ALLERGY AND CONGESTION RELIEF to update its labeling. The product combines chlorpheniramin…
-
CLINICAL_TRIALS trial_result · 2019-09-04Clinical Trial Update: A Novel Biologic Therapy for Perennial Allergic Rhinitis [Phase 2]
Phase 2 trial update for a novel biologic therapy targeting perennial allergic rhinitis; results completed with posted data.